5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.42▼ | 0.42▼ | 0.42▼ | 0.41▼ | 0.44▼ |
MA10 | 0.42▼ | 0.42▼ | 0.41▼ | 0.40▲ | 0.44▼ |
MA20 | 0.41▲ | 0.41▲ | 0.41▲ | 0.42▼ | 0.54▼ |
MA50 | 0.40▲ | 0.40▲ | 0.41▲ | 0.44▼ | 1.01▼ |
MA100 | 0.41▲ | 0.42▼ | 0.44▼ | 0.54▼ | 1.44▼ |
MA200 | 0.45▼ | 0.44▼ | 0.45▼ | 0.83▼ | 2.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.001▲ | 0.002▲ | 0.004▲ | 0.025▲ |
RSI | 54.536▲ | 55.350▲ | 54.866▲ | 44.861▼ | 37.651▼ |
STOCH | 78.806 | 86.931▲ | 87.452▲ | 60.726 | 22.311 |
WILL %R | -32.536 | -32.536 | -32.075 | -58.410 | -89.638▼ |
CCI | 4.720 | 17.725 | 27.734 | -3.583 | -75.582 |
Wednesday, March 27, 2024 05:53 PM
InvestorPlace - Stock Market News, Stock Advice & Trading Tips BioCardia (NASDAQ:BCDA) just reported results for the fourth quarter of ...
|
Wednesday, March 27, 2024 09:11 AM
BioCardia BCDA reported its Q4 earnings results on Wednesday, March 27, 2024 at 04:00 AM. Here's what investors need to know about the announcement. BioCardia beat estimated earnings by 18.0%, ...
|
Wednesday, March 27, 2024 09:00 AM
SUNNYVALE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
28/03/24 | 0.39 | 0.415 | 0.39 | 0.407 | 286,312 |
27/03/24 | 0.4175 | 0.427 | 0.4175 | 0.4191 | 142,893 |
26/03/24 | 0.41 | 0.42 | 0.41 | 0.42 | 251,806 |
25/03/24 | 0.399 | 0.4177 | 0.39 | 0.405 | 110,850 |
22/03/24 | 0.39 | 0.42 | 0.39 | 0.409 | 242,568 |
21/03/24 | 0.391 | 0.4195 | 0.391 | 0.40 | 135,575 |
20/03/24 | 0.395 | 0.40 | 0.3902 | 0.40 | 89,796 |
19/03/24 | 0.393 | 0.393 | 0.392 | 0.392 | 186,365 |
18/03/24 | 0.39 | 0.4093 | 0.3863 | 0.3863 | 119,817 |
15/03/24 | 0.39 | 0.4078 | 0.39 | 0.39 | 155,697 |
|
|
||||
|
|
||||
|
|